Q2i is an enterprise class software-as-a-service digital health company. We innovate, develop and supply evidenced based technology that improves treatment for Substance Use Disorder (SUD). Our solutions consist of mobile apps connecting to a CareTeam portal. They improve connection, communication, support and insight and increase availability, accessibility and program success.

Opioid Addiction Recovery Support

For: Primary Care Providers who want to improve the success of their MOUD treatment program, increase treatment plan adherence, reduce program drop outs and reduce missed appointments.

Opioid Addiction Recovery Support-CM

For: Emergency and acute care departments who want to improve the successful transition of their patients to out patient care and reduce hospital readmissions

Continuing Alumni Support Application

For: Residential or intensive outpatient treatment programs that want to improve post treatment care and long-term success of their patients recovery

Probation and Reentry Coach Application

For: Justice Teams who want to reduce revocation and recidivism and improve the success rate of their probation and reentry programs

Results Using Q2i Technology

Improves Patient Engagement

Patient Portals (SUD)

Q2i’s Patient Mobile App

Results Using Q2i Technology

Increases Patient Adherence to Treatment Plan*

National MAT Average

Q2i’s OARS Technology

* Based on Urine Toxicology Results (Opioid Negative)

100% Cloud, ready-to-go
Modern User Interface
HIPAA Compliant
Flexible and Scalable

Easy, Secure Video Telehealth

OARS has in-built secure, encrypted, HIPAA-compliant Telehealth video. The Care Team can schedule and run one-to-one or group Telehealth sessions directly from their OARS dashboard. Patients can easily and conveniently access sessions from within their OARS mobile app. This keeps all their treatment support in one place and has the added benefits of the OARS calendar of appointments, and alerts for upcoming sessions, making them easy to manage.

Academic Partners/Clinical Studies
Reward Based Technology to improve opioid use disorder treatment initiation after an ED visit
Technology Improving Medication-Assisted Treatment in Primary Care
Digital Health Technology Improving Successful Reintegration of Recently Released Justice-Involved Individuals with Substance Use Disorders
Ease of Use Feedback
PROVIDER QUOTES
I think it's very easy. Nobody really had to explain anything. They just had to set it up and I was able to use it

I just got right into it. It was pretty self-explanatory. It was one of the easiest apps I've used.

PATIENT QUOTES
Very user friendly I have to say. Like really, it was very simple to navigate, I am not IT savvy at all. If I tell you it was easy, it was easy

My patients seem to really like it. It was very easy to use. I think it was just a positive experience.

Communication Feedback
PROVIDER QUOTES
What I really liked is how I knew what was going on in my patient's life. I feel like it allowed me to give more informed care

I think it helped being able to connect with the patient more than just at their appointments.

PATIENT QUOTES
It makes it much more convenient. I don't feel like I'm hoping for a call back. I know she got my message and I know that she's going to get back to me. It gives me more confidence that the communication is going to occur.

It was good. It helped me relieve a lot of my stress and frustrations and it helped me communicate with my doctor a little better.

Engagement Feedback
PROVIDER QUOTES
It gave a more holistic approach. You can see all aspects of their treatment and see like how compliant they are in all aspects.

It was just easier to keep track of everything, and especially with the color coding. And it's easier to be in contact with the patients.

PATIENT QUOTES
I really like the journaling. I really enjoy that part because it gives me a more sense of what's going on with myself. But it's not even just about me, but it gives my doctor a chance to kind of see what's going on with me when I might see her once a month and you try to tell somebody what's going on in that timeframe and it's kind of hard
previous arrowprevious arrow
next arrownext arrow
Slider

Results Using Q2i Technology

Improves Patient Engagement

  • Patient Portals (SUD) 11.2% 11.2%
  • Q2i’s Patient Mobile App 85% 85%

Increases Patient Adherence to Treatment Plan*

  • National MAT Average 50% 50%
  • Q2i’s OARS Technology 92% 92%

* Based on Urine Toxicology Results (Opioid Negative)

%

Extra Provider Revenue

Missed appointments lead to lost revenue for providers. Patients using OARS attend more appointments than the national average for MAT patients by >32%. 

NIH/UCLA Phase 1 Responses

Technology Improving Medication-Assisted Treatment in Primary Care
A recent study of OARS in a primary care setting found that both primary care providers and MOUD patients felt that:

  1. OARS is easy to use
  2. OARS improves patient-provider communication
  3. OARS improves patient engagement in treatment

 Ease of Use

Provider Feedback

Very user friendly I have to say. Like really, it was very simple to navigate, I am not IT savvy at all. If I tell you it was easy, it was easy

My patients seem to really like it. It was very easy to use. I think it was just a positive experience.

It was easy, user friendly, very easy to adapt with.

It’s easy to use, it’s very user friendly. And I liked the color coding.

Patient Feedback

I think it’s very easy. Nobody really had to explain anything. They just had to set it up and I was able to use it

I just got right into it. It was pretty self-explanatory. It was one of the easiest apps I’ve used.

Yeah, it was so simple to use. Everything’s right there big on the homepage. So, it’s like you don’t have to go to a menu and then search or scroll. It’s like everything was right there.

I had no problem at all. A new person that never used the portal before would be able to use it. It’s real easy and self-explanatory

 Communication

Provider Feedback
Patients liked being able to look at the phone and connect with me. We do have a patient portal, but it’s cumbersome, and it’s hard to get access through your phone. You can, but it’s hard. So I think that that opened that communication line.

I think it helped being able to connect with the patient more than just at their appointments.

What I really liked is how I knew what was going on in my patient’s life. I feel like it allowed me to give more informed care

It can help bridge that gap where you can have more communication with the patient and they can readily assess the information.

Patient Feedback

I think that with the OARS app, I have a better relationship, a patient-doctor relationship, where my doctor has a better understanding of who I am, where I’m at, and why I’m in this state that I’m in with everything that’s going on. I think it changed it dramatically in a very, very positive way.

It makes it much more convenient. I don’t feel like I’m hoping for a call back. I know she got my message and I know that she’s going to get back to me. It gives me more confidence that the communication is going to occur.

It was good. It helped me relieve a lot of my stress and frustrations and it helped me communicate with my doctor a little better.

I think it made my interactions with my doctor a lot better, because you feel that connectivity to them number one, when you have the app. And then also you’re more self-aware while you’re using the app.

 Engagement

Provider Feedback
I absolutely loved the journal and also being able to see all the metrics that we want to follow up with these patients in terms of their visits and UDS and stuff like that we could actually see on one page.

It gave a more holistic approach. You can see all aspects of their treatment and see like how compliant they are in all aspects.

It was just easier to keep track of everything, and especially with the color coding. And it’s easier to be in contact with the patients.

I think at a glance, it could help to organize the information, the data regarding patient care, which can impact the decision making.

Patient Feedback

I really like the journaling. I really enjoy that part because it gives me a more sense of what’s going on with myself. But it’s not even just about me, but it gives my doctor a chance to kind of see what’s going on with me when I might see her once a month and you try to tell somebody what’s going on in that timeframe and it’s kind of hard

Anything that makes managing opioid dependence easier, I am all for. I highly recommend this app for doing that. The one thing that is left out of opioid dependency management a lot is the humanity in it. And this allows more convenience for the patient rather than being demanding of the patient. And I think that’s a really big deal

It was good because it made me figure out that I might not be at the right dosage and that certain journal entries provoked thought about maybe I was needing to get more medications, so I think it was extremely helpful

If you can look back through your journaling, and if you look back through your urines and everything, and you see that you’re maybe messing up in some places, you can look back on that and see what in your life is going on that’s making you do these things and just reflect back on some things that you might see that you need to work on

100% Cloud, ready-to-go

Start using Q2i to support your program in minutes – easily setup and manage your clinic and patients.
f

Modern User Interface

The Q2i healthcare team portal and patient app interface is intuitive and easy to navigate for an unequalled user experience.
0

Flexible and Scalable

Q2i can be used as a stand alone program management solution or easily integrated with your existing EHR.

HIPAA Compliant

Q2i is proud to be HIPAA compliant. All data policies are designed to meet or exceed HIPAA’s requirements.

Solutions

Opioid Addiction Recovery Support

For: Primary Care Providers who want to improve the success of their MOUD treatment program, increase treatment plan adherence, reduce program drop outs and reduce missed appointments. 

OARS improves MOUD treatment. It provides improved connection, management and support of patients, especially between appointments. OARS provides risk of drop of indicators, Telehealth and many features that combine to improve MOUD treatment programs. It has been shown to increase engagement, adherence to treatment plan and reduce missed appointments. More >>

Opioid Addiction Recovery Support-CM

For: Emergency and acute care departments who want to improve the successful transition of their patients to out patient care and reduce hospital readmissions.

OARS–CM, based on our award wining OARS platform, it encompasses reward-based technology designed by Contingency Management experts at UCONN. It seamlessly calculates and then delivers rewards against targeted behaviors. It provides gamification to deliver high impact, extremely economical results with low burden for clinical staff while maintaining maximum fidelity. More >>

Continuing Alumni Support Application

For: residential or intensive outpatient treatment programs that want to improve post treatment care and long-term success of their patients recovery.

CASA provides the care team of a residential or intensive outpatient detox program with ongoing connection to their alumni. It supports and improves navigation back into the community and enables establishing a network of sober friends and tools to improve long-term recovery success. More >>

Probation And Reentry Coach Application

For: Justice Teams who want to reduce revocation and recidivism and improve the success rate of their probation and reentry programs.

Probation And Reentry Coach Application helps Justice Teams by increasing connection, insight and support for successful community supervision. It helps JIPs set goals and accomplish them by connecting them to local healthcare, SUD treatment, Employment, Housing and other services that help address the SDOH. More >>

About Q2i

Our Mission 

Our mission is to design, develop, then supply the most advanced technologies that enable care teams to improve the success of their Substance Use Disorder treatment programs and interventions.

Our Vision

Our vision is to drive innovation in order to increase the availability, accessibility and success of treatment so that everyone seeking recovery from Substance Use Disorder can obtain the treatment they need in a manner both convenient and effective.

About

Q2i is a software as a service HealthTec company, specializing in developing applications that support recovery from OUD/SUD. Q2i was formed in 2016 as a result of the devastation occurring in our local communities caused by the opioid epidemic and to work to design technology that supports and improves recovery and help save lives.

Q2i collaborates with multidisciplinary healthcare teams, providers and payers to understand and then realize unmet technology needs. We facilitate improvements in patient care by supporting patients with their treatment plans through better connection and information exchange with their healthcare teams.

Q2i develops technology that assists health care providers in achieving the IHI quadruple aim of improving the patient experience of care (including quality and satisfaction), improving the health of populations, reducing the per capita cost of health care and improved clinician experience.

Contingency Management

Contingency Management (CM) is a reward-based intervention built on the principles of operant conditioning to promote behavior change and reinforce positive behaviors. CM delivers tangible monetary-based rewards contingent upon targeted outcomes or behaviors.

CM has demonstrated efficacy for improving abstinence and other substance use disorder (SUD) treatment outcomes in a diverse range of treatment populations and settings.

Q2i has partnered with Dr. Sheila M. Alessi, Ph.D. from the University of Connecticut. Dr. Alessi and her colleagues at UConn are experts in the field of contingency management. Their goal is to bring CM techniques from research to practice to improve outcomes for OUD/SUD patients.

Difficulties with traditional CM programs include the requirement for intensive hands-on management and oversight to maintain program fidelity. This requires highly trained staff to manage supervision and additional staff to manage the backend operation, such as purchasing of rewards and accounting.

Q2i’s solutions overcome these difficulties by digitizing and automating traditional contingency management and seamlessly integrating it into the cutting-edge Opioid Addiction Recovery Support (OARS) technology. OARS with CM addresses all long-term sustainability challenges while maintaining program fidelity.

OARS with CM, a mobile technology-enabled contingency management program, is a significant scientific and clinical advancement to improve treatment for OUD, SUD, and MAT programs.

Easy, Secure Video Telehealth

OARS has in-built secure, encrypted, HIPAA-compliant Telehealth video. The Care Team can schedule and run one-to-one or group Telehealth sessions directly from their OARS dashboard. Patients can easily and conveniently access sessions from within their OARS mobile app. This keeps all their treatment support in one place and has the added benefits of the OARS calendar of appointments, and alerts for upcoming sessions, making them easy to manage.

Academic Partners/Clinical studies

NIH/National Institute of Drug Abuse funded clinical studies in progress with Q2i’s academic partners

Reward Based Technology to improve opioid use disorder treatment initiation after an ED visit

Increasing the demand and reach of effective Medication Assistance Treatment (MAT) for opioid use disorder (OUD) is critical to decreasing OUD associated morbidity, mortality, and economic consequences. The technology breakthrough to be studied in this project will give individuals with OUD access to a smartphone application designed to help support initiation and adherence with MAT treatment regimens through patient-oriented educational and monitoring features, as well as a new evidence-based reward function shown in other research to promote treatment adherence, improve abstinence, and improve other health outcomes. The intervention will aim to facilitate the entire treatment trajectory, starting with initial transition from an acute care setting to outpatient MAT initiation and continuing through successful transition to maintenance.

NIH/NIDA Grant Number: 
1R42DA049448-01

Technology Improving Medication-Assisted Treatment in Primary Care

With over 72,000 overdose deaths in 2017, of which 47,600 are attributable to opioid overdose, the opioid epidemic has become North America’s most widespread behavioral public health problem. Medication assisted treatment (MAT) for opioid use disorder (OUD) is highly efficacious. The Opioid Addiction Recovery Support (OARS) comprises of a healthcare team portal connected to a patient mobile application, to provide opioid related education, promote connectedness with clinicians, and track MAT treatment progress. This STTR Fast Track proposal will conduct interviews with patients that will inform optimal design of OARS and utilize a “stepped wedge” effectiveness design to assess the effectiveness of OARS in improving opioid agonist treatment outcomes in primary care settings and evaluate sustainability and return on investment.

NIH/NIDA Grant Number: 
1R42DA050398-01

Digital Health Technology Improving Successful Reintegration of Recently Released Justice-Involved Individuals with Substance Use Disorders

Of the 2 million individuals that are confined nationwide 10,000 are released weekly with inadequate support solutions that comprehensively address social determinants of health resulting in a high recidivism rate. The lack of support can significantly affect health outcomes, especially for recently released justice-involved individuals with substance use disorder (SUD). Digital health technology can help recently released individuals navigate and adapt to their new environment. Technology makes it possible to provide localized support – such as access to location-specific information about risk reduction, housing, accessing medical care, SUD treatment programs and availability, and support groups – that is not available through traditional mechanisms. It transforms support services from fragmented, disparate services to centralized, one-stop shopping that is available 24/7 for people in need.

NIH/NIDA Grant Number: 
1R41DA051156-01

 

Leadership Team

Steven Jenkins

Steven Jenkins

CEO

Steven Jenkins has over 20 years of senior management experience in the technology and HealthTech sectors in North America and Europe.

More »

Gerald A. Kraines, M.D.

Gerald A. Kraines, M.D.

CMO

Gerald A. Kraines, M.D. a faculty member at Harvard Medical School for over 30 years…

More »

Tony McNamara

Tony McNamara

CTO

Tony McNamara has over 15 years of experience driving innovation in medical technology companies.

More »

Monica Strunk

Monica Strunk

Director, Grants and Strategic Partnerships

Monica has over 20 years of experience in fundraising, strategic planning…

More »

Medical Advisory Board

Q2i’s Medical Advisory Board provides in-depth subject matter expertise across a broad spectrum of healthcare delivery. This diverse composition provides a strong group dynamic providing insight and scientific direction. This ensures Q2i’s solutions not only improves patient outcomes and helps health systems and payers create value but that we go beyond traditional clinical efficacy to capture newer patient-focused considerations and impact the effectiveness and efficiency of care delivered under new value-based performance systems.

Sara M. Bolton

Sara M. Bolton

M.D.

Dr. Bolton is an assistant clinical professor of psychiatry at Harvard Medical School and an associate psychiatrist at McLean Hospital.

More »

Gary Chinman

Gary Chinman

M.D

Dr. Chinman is assistant professor of psychiatry at Harvard Medical School and president of the Massachusetts Psychiatric Society.

More »

Guy Slater

Guy Slater

FRCS

Guy is a consultant surgeon specializing in laparoscopic gastro-intestinal surgery and weight loss surgery.

More »

Jeremy Vigneault

Jeremy Vigneault

PT, MSPT, OCS, Cert. MDT

Jeremy is a faculty member in the Department of Kinesiology and is the Director of the Nayden Rehabilitation Clinic.

More »

Jennifer Davenport

Jennifer Davenport

MD, MHA, FSCAI

Dr. Jennifer Davenport is a Medical Director and Director of Interventional Cardiology. She has a Masters in Health Systems Administration and Policy.

More »

P. Elizabeth Thomas

P. Elizabeth Thomas

MD

Dr. Thomas is board certified by the American Board of Pediatrics and the American Board of Pediatric Cardiology.

More »

Q2i in the News

July 20, 2021

Q2i’s reward-based digital technology moves to Phase II of National Institutes of Health (NIH) clinical trial to further evaluate the application’s efficacy in increasing treatment adherence for substance use disorder after an ED Visit.

Read more ›

Feb 25, 2021

Q2i’s OARS software application moves to Phase II of National Institute of Health (NIH) clinical trial which will evaluate the application’s efficacy in improving Opioid Use Disorder treatment

Read more ›

April 28, 2020

Q2i Awarded NIH/NIDA Grant to Develop and Evaluate Digital Technology to Improve Successful Community Reintegration of Recently Released Justice-Involved Individuals With Substance Use Disorders

Read more ›

Jan 7, 2020

Q2i Awarded NIH/NIDA Grant to Develop and Evaluate Digital Technology to Improve Medication-Assisted Treatment in Primary Care

Read more ›

Oct 17, 2019

Q2i Awarded NIH/NIDA Grant to Develop and Evaluate Loyalty/Reward-based Digital Technology to Increase Medication Adherence for Substance Use Disorder after an ED Visit

Read more ›

Sept 4, 2019

Beacon Health Options announce they have selected Q2i’s OARS technology in a grant award to address the opioid crisis.

Read more ›

Feb 6, 2019

The Haven Substance Abuse Recovery Center Adopts Q2i’s CASA Technology to Increase Efficacy of After-Treatment Care

Read more ›

Jan 8, 2019

Q2i Adds Telehealth Capabilities to Its Solutions, Improving Availability and Access to Recovery from Opioid Addiction

Read more ›

Nov 15, 2018

Q2i’s Outcome-Measures Software Helping Improve Quality of Treatment for Substance Use Disorder

Read more ›

Oct 9, 2018

Q2i’s New MATRA Technology Enables Earliest Interventions to Improve Recovery from Opioid Use Disorder

Read more ›

Sep 20, 2018

Harbor Homes becomes first healthcare organization in New Hampshire to utilize OARS technology to improve treatment for opioid use disorder

Read more ›

Sep 6, 2018

Maine-Based Door to Door Doctors Deploys Q2i’s OARS Technology to Support Patients Recovering from Opioid Use Disorder

Read more ›

April 24, 2018

The PILLARS Recovery Center Deploys Q2i’s CASA Technology To Better Support People In Recovery from Substance Abuse
Read more ›

Mar 22, 2018

Alyssa’s Place: Peer Recovery Center Deploys Q2i’s CASA Technology to Improve After-Treatment Care of Substance Use Disorder Patients.
Read more ›

Mar 8, 2018

Q2i Partners with athenahealth’s ‘More Disruption Please’ Program to Enable Providers to Gain Insight into OUD Patients’ Recovery Progress and Improve Patient Outcomes.
Read more ›

Jan 16, 2018

Q2i launches CASA, technology supporting residential and outpatient recovery clinics with their after treatment programs.
Read more ›

Dec 29, 2017

Q2i launches Bari-Well, technology supporting bariatric programs and patients with long-term weight loss.
Read more ›

August 24, 2017

Technology proving successful in supporting fight against opioid epidemic – Q2i announce that Heywood Medical Group is utilizing its Opioid Addiction Recovery Support (OARS) software to support patients with addiction recovery.
Read more ›

July 18, 2017

Using Technology to Battle the Opioid Epidemic – Health Tech Company, Q2i, Launches its Innovative behavioral healthcare management software, OARS.
Read more ›

Upcoming Events

Q2i and our solutions will be on display at the 2021 WCSAD Conference from September 29th – October 3rd where will be showcasing our OARS and OARS+Contingency Management solution.
Visit us at Booth 206, see you there!

Q2i’s OARS & OARS+Contingency Management solution will be on display at the 2021 WCSAD Annual Conference in La Quinta, CA. For more information on the WCSAD Conference, click the link below.
View WCSAD Meeting Details

Q2i’s OARS & OARS+Contingency Management solution will be on display at the 2021 NAADAC Virtual Meeting from October 28th – 30th

Q2i’s OARS & OARS+Contingency Management solution will be on display at the 2021 NAADAC Virtual Conference. For more information on the NAADAC Virtual Conference click the link below.
View NAADAC Virtual Meeting Details

Contact Q2i

(P) 617.812.2602
1660 Soldiers Field Rd.
Brighton, MA 02135